Nancy E. Kohl

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Biology and Biochemistry D-index 53 Citations 11,945 100 World Ranking 11459 National Ranking 4929

Overview

What are the main themes of her work throughout her whole career to date

Cancer research and Oncology are two areas of study in which Nancy E. Kohl engages in interdisciplinary research. She performs integrative study on Oncology and Pathology in her works. Her study ties her expertise on GiST together with the subject of Pathology. GiST and Cancer research are commonly linked in her work. Nancy E. Kohl undertakes multidisciplinary studies into In vivo and Pharmacokinetics in her work. She merges Pharmacokinetics with Pharmacology in her study. She integrates Pharmacology and Biotechnology in her research. Her research on Biotechnology frequently connects to adjacent areas such as In vivo. Cancer is often connected to Tyrosine-kinase inhibitor in her work.

Nancy E. Kohl most often published in these fields:

Cancer research (100.00%)
In vivo (80.00%)
Cancer (60.00%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Active human immunodeficiency virus protease is required for viral infectivity.

Nancy E. Kohl;Emilio A. Emini;William A. Schleif;Lenora J. Davis.
Proceedings of the National Academy of Sciences of the United States of America (1988)

1887 Citations

Transposition and amplification of oncogene-related sequences in human neuroblastomas

Nancy E. Kohl;Naotoshi Kanda;Rhona R. Schreck;Gail Bruns.
Cell (1983)

893 Citations

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.

NE Kohl;SD Mosser;SJ deSolms;EA Giuliani.
Science (1993)

801 Citations

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

Kohl Ne;Omer Ca;Conner Mw;Anthony Nj.
Nature Medicine (1995)

675 Citations

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic.

Jackson B. Gibbs;Allen Oliff;Nancy E. Kohl.
Cell (1994)

650 Citations

Differential expression of myc family genes during murine development

Kathryn A. Zimmerman;George D. Yancopoulos;Robert G. Collum;Russell K. Smith.
Nature (1986)

600 Citations

A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines

Laura Sepp-Lorenzino;Zhenping Ma;Elaine Rands;Nancy E. Kohl.
Cancer Research (1995)

542 Citations

Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.

N E Kohl;F R Wilson;S D Mosser;E Giuliani.
Proceedings of the National Academy of Sciences of the United States of America (1994)

426 Citations

Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.

J. B. Gibbs;D. L. Pompliano;S. D. Mosser;E. Rands.
Journal of Biological Chemistry (1993)

397 Citations

Induction of Apoptosis by an Inhibitor of the Mitotic Kinesin KSP Requires Both Activation of the Spindle Assembly Checkpoint and Mitotic Slippage

Weikang Tao;Victoria J. South;Yun Zhang;Joseph P. Davide.
Cancer Cell (2005)

382 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Nancy E. Kohl